Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

WSTNWestin Acquisition Corp

Nasdaq · CIK 0002076192
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC8011 Services-Offices & Clinics of Doctors of Medicine
FY end0630
XBRL facts53

Identity from submissions API

NameWestin Acquisition Corp
CIK0002076192
TickersWSTN, WSTNR, WSTNU
ExchangesNasdaq, Nasdaq, Nasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC8011 Services-Offices & Clinics of Doctors of Medicine
EIN000000000
LEI—
Fiscal year end0630
State of incorporationE9 Cayman Islands
Phone65 9488 4425
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
SUITE 1165-L 3 COLEMAN STREET #03-24
SINGAPORE
179804
Singapore
U0
Mailing address
SUITE 1165-L 3 COLEMAN STREET #03-24
SINGAPORE
179804
Singapore
U0

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

45 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 10-Q 10-Q 0001493152-26-052011 001-42926 261555427 34 3274989 1 1
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001072613-26-000887 005-95323 261552489 34 7955
2026-11-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-125858 005-95323 261543272 34 33606
2026-11-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001628280-26-072433 005-95323 261537418 34 80117
2026-10-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001140361-26-038760 005-95323 261442930 34 12709
2026-09-29 10-K ANNUAL REPORT 0001213900-26-104251 001-42926 261418827 34 3519253 1 1
2026-09-28 10-Q/A AMENDMENT NO. 1 TO FORM 10-Q 0001213900-26-103652 001-42926 261411613 34 3176939 1 1
2026-09-28 10-Q/A AMENDMENT NO. 1 TO FORM 10-Q 0001213900-26-103649 001-42926 261411598 34 3261611 1 1
2026-07-29 425 CURRENT REPORT 0001213900-26-082414 001-42926 261213130 34 889164
2026-07-29 8-K CURRENT REPORT 1.01,5.01,7.01,9.01 0001213900-26-082408 001-42926 261213107 34 1311263 1 1
2026-07-28 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001213900-26-082465 005-95323 261213615 34 45419
2026-07-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001140361-26-028387 005-95323 261173047 34 13372
2026-05-15 10-Q QUARTERLY REPORT 0001213900-26-057804 001-42926 26987913 34 3104779 1 1
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001072613-26-000438 005-95323 26979099 34 7907
2026-03-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001072613-26-000248 005-95323 26731053 34 7688
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-000874 005-95323 26637296 34 9080
2026-02-13 10-Q QUARTERLY REPORT 0001213900-26-016422 001-42926 26633059 34 3057729 1 1
2026-02-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001376474-26-000119 005-95323 26597778 34 13097
2026-01-06 25-NSE xslF25X02/primary_doc.xml 0001354457-26-000012 333-288889 26511263 34 3207
2025-12-31 8-K CURRENT REPORT 8.01,9.01 0001213900-25-126818 001-42926 251615755 34 259947 1 1
2025-12-30 25-NSE xslF25X02/primary_doc.xml 0001354457-25-001301 333-288889 251615000 34 3093
2025-12-23 8-K CURRENT REPORT 8.01,9.01 0001213900-25-124959 001-42926 251595645 34 259448 1 1
2025-12-12 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-121186 005-95323 251568203 34 17068
2025-12-10 3 OWNERSHIP DOCUMENT 0001213900-25-120173 6025
2025-12-10 3 OWNERSHIP DOCUMENT 0001213900-25-120170 3203
2025-12-10 3 OWNERSHIP DOCUMENT 0001213900-25-120169 3197
2025-12-10 3 OWNERSHIP DOCUMENT 0001213900-25-120168 3206
2025-12-10 3 OWNERSHIP DOCUMENT 0001213900-25-120166 6399
2025-12-10 3 OWNERSHIP DOCUMENT 0001213900-25-120164 3191
2025-11-21 10-Q QUARTERLY REPORT 0001213900-25-113607 001-42926 251507968 34 2227816 1 1
2025-11-13 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-25-109956 001-42926 251478135 34 24535
2025-11-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001376474-25-000915 005-95323 251475135 34 12768
2025-11-12 8-K CURRENT REPORT 8.01,9.01 0001213900-25-108743 001-42926 251469043 34 386766 1 1
2025-11-06 8-K CURRENT REPORT 1.01,3.02,5.02,5.03,8.01,9.01 0001213900-25-107058 001-42926 251457386 34 2013462 1 1
2025-11-05 424B4 PROSPECTUS 0001213900-25-106546 333-288889 251453098 33 1701826
2025-11-03 CERT WSTN_8A_Cert_2076192.pdf 0001354457-25-001086 001-42926 251445231 34 595479
2025-10-29 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-25-103537 001-42926 251430837 34 25302
2025-10-10 S-1/A AMENDMENT NO. 3 TO FORM S-1 0001213900-25-098103 333-288889 251387919 33 3661977 1 1
2025-09-17 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-25-088450 333-288889 251319297 33 5644983 1 1
2025-09-17 CORRESP filename1.htm 0001213900-25-088451 7916
2025-08-29 UPLOAD filename1.pdf 0000000000-25-009315 333-288889 42825
2025-08-25 CORRESP filename1.htm 0002077096-25-000050 20760
2025-08-25 S-1/A AMENDMENT NO. 1 TO FORM S-1 0002077096-25-000049 333-288889 251251104 33 3948689 1 1
2025-08-19 UPLOAD filename1.pdf 0000000000-25-008743 333-288889 50751
2025-07-23 S-1 REGISTRATION STATEMENT 0001213900-25-066996 333-288889 251143457 33 4758049 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (53 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 8.05M 2026-11-13 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
dei EntityPublicFloat Entity Public Float USD 0 2026-06-30 2026 FY 10-K 2026-09-29 0001213900-26-104251
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 127,000 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 978,646 2026-06-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 978,646 2026-06-30 2026 FY 10-K 2026-09-29 0001213900-26-104251
us-gaap AdministrativeFeesExpense Administrative Fees Expense USD 30,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap Assets Assets USD 59.47M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap AssetsCurrent Assets, Current USD 55,062 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 59.42M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles USD 5.00M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap Cash Cash USD 55,062 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 319,009 2026-06-30 2026 FY 10-K 2026-09-29 0001213900-26-104251
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 55,062 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 319,009 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-29 0001213900-26-104251
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations USD -263,947 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 319,009 2026-06-30 2026 FY 10-K 2026-09-29 0001213900-26-104251
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 2.16M 2025-11-05 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 2.30M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.002 2025-07-01 2025-09-30 2026 Q1 10-Q 2025-11-21 0001213900-25-113607
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.002 2025-07-01 2025-09-30 2026 Q1 10-Q 2025-11-21 0001213900-25-113607
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 235,944 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -28,003 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 538,560 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap Liabilities Liabilities USD 2.88M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 59.47M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap LiabilitiesCurrent Liabilities, Current USD 576,377 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 58.15M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-29 0001213900-26-104251
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -57.50M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-29 0001213900-26-104251
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -263,947 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 302,616 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 4,339 2025-07-01 2025-09-30 2026 Q1 10-Q 2025-11-21 0001213900-25-113607
us-gaap OperatingExpenses Operating Expenses USD 235,944 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap OtherBorrowings Other Borrowings USD 449,377 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.70M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-29 0001213900-26-104251
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 10.00M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 57.50M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-29 0001213900-26-104251
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 57.50M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-29 0001213900-26-104251
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 2.35M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-29 0001213900-26-104251
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 10,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD 311,971 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap SharePrice Share Price USD/shares 10 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 312,201 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 25,000 2025-06-03 2025-06-30 2026 FY 10-K 2026-09-29 0001213900-26-104251
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 2.35M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-29 0001213900-26-104251
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 4.81M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-29 0001213900-26-104251
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 56.29M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap TemporaryEquityNetIncome Temporary Equity, Net Income USD -1.55M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2027 Q1 10-Q 2026-11-16 0001493152-26-052011
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1.75M 2025-07-01 2025-09-30 2026 Q1 10-Q 2025-11-21 0001213900-25-113607
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 1.75M 2025-07-01 2025-09-30 2026 Q1 10-Q 2025-11-21 0001213900-25-113607

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →